Objectives: Urinary tract infection (UTI) is an adverse effect of sodium-glucose cotransporter 2 inhibitors (SGLT2i). However, its effect on cardiovascular outcomes in type 2 diabetes mellitus (T2DM) patients remains unclear.
Methods: This multicenter retrospective observational study included diabetes patients who received SGLT2 inhibitors (SGLT2i) between January 2016 and January 2019. Major adverse cardiovascular events (MACEs) were defined as a composite of non-fatal myocardial infarction, non-fatal stroke, cardiac death, all-cause death, or hospitalization due to heart failure. Outcomes were compared between patients with and without urinary tract infection (UTI). Multivariate analyses were conducted to adjust for baseline characteristics that might influence the outcomes.
Results: We retrospectively reviewed 8862 T2DM patients who had been treated with SGLT2i. In total, 550 patients were identified as having UTIs and requiring antibiotics after SGLT2i treatment. We followed up on the cardiovascular outcomes for 30 months after SGLT2i treatment. After adjusting significant baseline characters, the UTI group exhibited increased risk of MACE (aHR=2.03, 95% CI=1.60-2.57, p<0.0001), heart failure hospitalization (aHR=1.66, 95% CI=1.32-2.09, p<0.0001), and all-cause mortality (aHR=2.67, 95% CI=2.10-3.40), p<0.0001).
Conclusions: UTI in patients with T2DM post-SLGT2i therapy is associated with an increased risk of MACE for up to 30 months.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.eprac.2025.02.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Revised Optical Coherence Tomography-Derived Calcium Score to Predict Stent Underexpansion in Severely Calcified Lesions.
JACC Cardiovasc Interv
March 2025
Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA; Division of Cardiology, Department of Medicine, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, USA.
Background: Severe calcification is the morphology most strongly associated with stent underexpansion.
Objectives: The aim of this study was to revise an optical coherence tomography (OCT)-derived calcium score to predict stent underexpansion in severely calcified lesions (angle >270°) using a point-based system.
Methods: A retrospective observational study was conducted in which 250 de novo lesions undergoing OCT-guided stenting, with angiographically visible calcium and optical coherence tomographic maximum superficial calcium angle >270°, not subjected to atherectomy or specialty balloon treatment before stent implantation, were randomly divided into derivation (n = 167) and validation (n = 83) cohorts.
Global Algorithm for the Endovascular Treatment of Chronic Femoropopliteal Lesions: An Interdisciplinary Expert Opinion Statement.
JACC Cardiovasc Interv
March 2025
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
A global treatment algorithm was developed for the endovascular revascularization of femoropopliteal lesions and chronic total occlusions, aiming toward a more standardized approach to endovascular treatment in patients with peripheral artery disease. The following steps are proposed. 1) Evaluation of lesion morphology based on preprocedural imaging by Duplex sonography and intravenous ultrasound for selection of lesion preparation tools.
View Article and Find Full Text PDFBest Practices for Imaging of Transcatheter Valve Failure: An Update From the Heart Valve Collaboratory.
J Am Coll Cardiol
March 2025
Cedars Sinai Medical Center, Los Angeles, California, USA. Electronic address:
This updated Heart Valve Collaboratory framework addresses the growing concern for transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR). With the increasing volume of redo-TAV and surgical TAV explantation, there is a critical need for standardized pathways and protocols for evaluating TVF using echocardiography and cardiac computed tomography (CT) angiography. This document clarifies prior definitions of bioprosthetic valve deterioration and bioprosthetic valve failure in a practical, imaging directed context for TAVR.
View Article and Find Full Text PDFThe Cardiovascular Epidemiology of Smoking: Past, Present, and Future.
J Am Coll Cardiol
March 2025
School of Medicine, University of Galway, Galway, Ireland; National Institute for Prevention and Cardiovascular Health, Galway, Ireland; Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address:
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy.
J Am Coll Cardiol
March 2025
National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.
Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed chronic disease associated with progressive heart failure that results in impaired quality of life, repeated hospitalizations, and premature death. Acoramidis is a selective, oral transthyretin stabilizer recently approved by the U.S.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!